Guideline Recommendations for Combined Use of Venlafaxine and Sumatriptan in Migraine Management

Dosing Recommendations

Sumatriptan acute‑treatment dosing – For adult migraine patients, the recommended oral dose is 25 mg to 100 mg per attack, with a maximum cumulative dose of 200 mg within any 24‑hour period. 1

Necessary cardiovascular screening – Before initiating sumatriptan, clinicians should assess patients for ischemic heart disease, cerebrovascular disease, peripheral vascular disease, or uncontrolled hypertension, as the drug is contraindicated in these conditions. 1

Limit frequency of sumatriptan use – To reduce the risk of medication‑overuse headache, sumatriptan should be used on fewer than 10 days per month in migraine sufferers. 2
Escalate preventive therapy when acute use is frequent – If a patient requires acute migraine medication more than twice per week, clinicians should optimize preventive treatment—venlafaxine is an evidence‑based option for both migraine prophylaxis and comorbid depressive symptoms. 3